{"id":6544,"date":"2025-12-04T14:56:35","date_gmt":"2025-12-04T13:56:35","guid":{"rendered":"https:\/\/hemerapharma.com\/?p=6544"},"modified":"2026-01-19T15:03:23","modified_gmt":"2026-01-19T14:03:23","slug":"hemera-pharma-on-tv-cristiana-vignolis-interview-on-tg2-on-rai-2","status":"publish","type":"post","link":"https:\/\/hemerapharma.com\/en\/hemera-pharma-on-tv-cristiana-vignolis-interview-on-tg2-on-rai-2\/","title":{"rendered":"Hemera on TV: Cristiana Vignoli\u2019s interview on TG2 on RAI 2"},"content":{"rendered":"<p>Hemera was featured on the TG2 national TV programme <a href=\"https:\/\/www.rainews.it\/rubriche\/tg2tuttoilbellochece\/video\/2025\/12\/TG2-Tutto-il-bello-che-ce-del-04122025-147c1f27-cb25-4dd4-b580-3a176ddcc94c.html\" target=\"_blank\" rel=\"noopener\"><em>\u201cTutto il bello che c\u2019\u00e8\u201d<\/em>,<\/a> aired on <strong>Thursday 4 December at 1:30 pm<\/strong>, with an interview with <strong><a href=\"https:\/\/hemerapharma.com\/en\/team\/cristiana-vignoli\/\">Cristiana Vignoli<\/a>, CEO of Hemera<\/strong>, following her recent award of the <strong>Bfactor Award <\/strong>promoted by the <a href=\"https:\/\/www.fondazionebellisario.org\/\" target=\"_blank\" rel=\"noopener\"><strong>Fondazione Marisa Bellisario<\/strong><\/a>.<\/p>\n<p>The interview provided an opportunity to present Hemera\u2019s mission and ongoing activities in the field of regenerative medicine, with a focus on <a href=\"https:\/\/hemerapharma.com\/en\/remast%ef%b8%8f\/\"><strong>REMaST\u00ae<\/strong><\/a>, the company\u2019s advanced cellular therapy under development for the <strong>regeneration of nervous tissue and the treatment of spinal cord injuries<\/strong>.<\/p>\n<p>Through the voice of its CEO, Hemera shared its vision of translating scientific research into innovative therapeutic solutions addressing a major <strong>unmet medical need<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CEO Hemera interviews on national italian TV TG2 <\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[31],"tags":[],"class_list":["post-6544","post","type-post","status-publish","format-standard","hentry","category-news-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/6544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/comments?post=6544"}],"version-history":[{"count":2,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/6544\/revisions"}],"predecessor-version":[{"id":6549,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/6544\/revisions\/6549"}],"wp:attachment":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/media?parent=6544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/categories?post=6544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/tags?post=6544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}